GENNEX LABORATORIES
Back to Cashflow Statement
|
GENNEX LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-11 Cr | ₹-47 Cr | ₹24 Cr | ₹12 Cr | ₹-1.44 Cr |
What is the latest Cash Flow from Operating Activities ratio of GENNEX LABORATORIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-11 Cr |
| Mar2024 | ₹-47 Cr |
| Mar2023 | ₹24 Cr |
| Mar2022 | ₹12 Cr |
| Mar2021 | ₹-1.44 Cr |
How is Cash Flow from Operating Activities of GENNEX LABORATORIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-11 Cr | Negative | |
| Mar2024 | ₹-47 Cr | Negative | |
| Mar2023 | ₹24 Cr | 98.82 | |
| Mar2022 | ₹12 Cr | Positive | |
| Mar2021 | ₹-1.44 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹242.7 Cr | -3.6% | 24.7% | -23.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -3.6% |
24.7% |
-23.6% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses